AVA-2100

N/A

Report date: 2025/01/26 18:07:19

Base Information

Drug NameAVA-2100
Drug Alias Nametherapeutic vaccine (Avalia Immunotherapies)AVA-2100
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvalia Immunotherapies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvalia Immunotherapies Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A